Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > I see a lot of

<< Previous

Bullboard Posts

Next >>

Comment by Moemoney42on Feb 01, 2021 10:09pm

139 Views

Post# 32444011

RE:RE:RE:I see a lot of

By the time THRM has its data set and appication to HC for approval.. then wait for HC to replicate the test and decide IF they give approval it will be the end of March... by this time many tests will be available as there are already many.. the clincher will be at what price if THRM gets approval can the produce them at <$5? If so is there a profit margin.. what level of dilution will have to take place to have funding enough to fill an order of any size..?? Lots of open ended questions folks with no guarantees.. use caution when investing.. JMHO

Smokey1958 wrote:
This test is still not SCV2 ....Thrm still in front for what the world is begging for!

"Because of the expected $30 cost and the need for a smartphone to receive results, this particular test is unlikely to be the game-changer several public health experts have been calling for — a test that families could use routinely at home before leaving the house, to prevent silent spread."

The Ellume contract is "a step in the right direction towards identifying fast tools that can actually help serve to identify and slow spread," says Dr. Michael Mina, a Harvard epidemiologist who has been a vocal advocate for widespread rapid tests. What's needed, he says, are "tests that are highly accessible, abundant, can be used frequently, provide immediately actionable results and are $5 [or less] per test. A test that does not meet each of these [criteria] will not perform well as a public health test to fight this pandemic."

billybob22 wrote: Just announced in the states that they are buying a 15 min test from a company from Australia